Has NICE guidance helped your organisation up its game? Enter the 2019 Shared Learning Awards
The 2019 Shared Learning Awards are now open for entries.
Latest news headlines
CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft guidance today (19 September).
19 September 2018
Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib.
17 September 2018
Procedure could be an option for adults with severe asthma whose symptoms cannot be adequately controlled with drugs
31 August 2018
CAR-T considered to be an exciting innovation which can cure some patients but very expensive
28 August 2018
People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks
23 August 2018
NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).
14 August 2018